In the third, final, and by most reckonings most inconsequential, national debate of the US presidential election, vice ...

Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...

The lawsuit, originally filed by the Roofers Local No. 149 Pension Fund in 2023, alleges that Amgen misled shareholders by ...

Seven new clinical trial grants were awarded under the Orphan Product Grants Program during the fiscal year (FY) 2024, ...

The month-long standoff between the US Health Resources and Services Administration (HRSA) and Johnson & Johnson came to an ...

UCB taps new UK head. Belgium-based global biopharmaceutical company UCB welcomed Nico Reynders as its new general manager ...

A functional point of contact (FPOC) is a dedicated liaison in each functional area responsible for evaluating and ...

South Korea has designated life sciences and biotechnology as priority areas for growth and leadership. The country is experiencing rapid growth in biotechnology thanks to continuous public and ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

Empathy is the ability to emotionally understand what other people feel, see things from their point of view, and imagine yourself in their shoes. It’s a fundamental aspect of any successful ...

The UK is currently amid negotiations on a new voluntary scheme, due to start in 2024, that sets out the framework for pricing and access to branded treatments. If it can be agreed, this will be a ...

This year was a year of significant new beginnings for pharma and healthcare, yet, it was still impacted by the long-term fallouts of the pandemic. 2024 will inherit the challenges of 2023 and see ...